{"id":136897,"date":"2010-01-04T17:08:13","date_gmt":"2010-01-04T22:08:13","guid":{"rendered":"http:\/\/www.xconomy.com\/?p=57059"},"modified":"2010-01-04T17:08:13","modified_gmt":"2010-01-04T22:08:13","slug":"sequenom-settles-sensigen-claims","status":"publish","type":"post","link":"https:\/\/mereja.media\/index\/136897","title":{"rendered":"Sequenom Settles SensiGen Claims"},"content":{"rendered":"\n
Medical Diagnostics<\/a>, Disputes<\/a>, settlements<\/a><\/div>\n

\t\tBruce V. Bigelow wrote:<\/strong><\/p>\n

San Diego-based Sequenom<\/a> (NASDAQ: SQNM<\/a>) disclosed in a regulatory filing<\/a> it has issued 367,547 additional shares of its common stock, valued at $1.5 million, to settle claims stemming from its acquisition of Ann Arbor, MI-based SensiGen’s molecular diagnostic tests. Sequenom and SensiGen said last January<\/a> the San Diego biotech was buying a variety of diagnostic tests from privately held SensiGen in a stock-and-cash deal valued at $8.7 million. The SensiGen principals who received an aggregate 71,836 shares as part of that deal notified Sequenom in July that they had suffered about $1.3 million in damages, based on Sequenom’s breached representations and warranties. Sequenom said a few months earlier that it had mishandled data from clinical trials for its non-invasive test for Down syndrome, a revelation that has triggered at least two federal investigations.<\/p>\n

Comments<\/a> | Reprints<\/a> | Share:  
\n\"Retweet\"\/<\/a>
\n \"Facebook\"\/<\/a>
\n \"Email\"\/<\/a>
\n \"Share\"\/<\/a>\n<\/div>\n

\t \t\t

\n

\n\"\"<\/a>
\n\"\"<\/p>\n

<\/img><\/a>
\n<\/img><\/a><\/p>\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

Medical Diagnostics, Disputes, settlements Bruce V. Bigelow wrote: San Diego-based Sequenom (NASDAQ: SQNM) disclosed in a regulatory filing it has issued 367,547 additional shares of its common stock, valued at $1.5 million, to settle claims stemming from its acquisition of Ann Arbor, MI-based SensiGen’s molecular diagnostic tests. Sequenom and SensiGen said last January the San […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"class_list":["post-136897","post","type-post","status-publish","format-standard","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/136897","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/comments?post=136897"}],"version-history":[{"count":0,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/136897\/revisions"}],"wp:attachment":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/media?parent=136897"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/categories?post=136897"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/tags?post=136897"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}